CERN and the JRC to scale up production of alpha-emitters against cancer
Wednesday, September 23, 2015 - 12:20
in Physics & Chemistry
A novel, accelerator-driven method could produce nuclides for targeted alpha therapy of cancer in practically unlimited amounts, overcoming current obstacles for its wider use due to a limited production of alpha-emitters. The JRC and the Conseil Européen pour la Recherche Nucléaire (CERN) have embarked to explore the potential of the jointly proposed method.